Oncology Times - OncTimes Talk
OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.
- Update frequency
- every 4 days
- Average duration
- 13 minutes
- Episodes
- 199
- Years Active
- 2009 - 2025
From Ironman to Advocate: Tom Hulsey’s Journey Through Prostate Cancer and Purpose
00:26:12 |
Fri 01 Aug 2025
Accurate and Actionable: How Oncologists Get Fast, Comprehensive Therapeutic Insights from the OncoExTra® Test
00:19:37 |
Thu 17 Jul 2025
Empowering Cancer Care Through Movement: A Conversation with Sami Mansfield
00:35:19 |
Tue 01 Jul 2025
Making Comprehensive Genomic Profiling More Accurate for Everyone: The Importance of Patient-Matched Tumor-Normal Sequencing
00:12:33 |
Wed 28 May 2025
Transforming colorectal cancer management with tumor informed ctDNA testing
00:14:25 |
Thu 22 May 2025
Mobile Prostate Cancer Screening Clinic Raises Prostate Cancer Early Detection Rates in Underserved Communities at High Risk
00:12:53 |
Thu 27 Mar 2025
Striking Microbiome Bacterial Population Differences Distinguish Metastatic Prostate Cancer From Non-Metastatic Disease
00:08:40 |
Mon 03 Mar 2025
Adjuvant Androgen Deprivation Therapy No Benefit After Surgery for High-Risk Prostate Cancer
00:09:41 |
Mon 03 Mar 2025
Novel Score Selects Patients With Intermediate Risk Prostate Cancer Safe for Active Surveillance
00:10:08 |
Mon 03 Mar 2025
Mobile Prostate Cancer Screening Clinic Raises Prostate Cancer Early Detection Rates in Underserved Communities
00:12:53 |
Mon 03 Mar 2025
KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma
00:07:33 |
Sat 25 Jan 2025
Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified
00:16:09 |
Mon 13 Jan 2025
Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma
00:07:25 |
Fri 10 Jan 2025
Disclaimer: The podcast and artwork embedded on this page are the property of Oncology Times. This content is not affiliated with or endorsed by eachpod.com.